

TCD IN OPHTHAMOLOGY
Multigon USA and Falck Medical Technologies has established a proven model of legitimate application in ophthalmology, to ensure TCD is only ordered when medically necessary. The Falck multifunction device is the only FDA cleared device that quantitates the mean central retinal artery (MCRAP) perfusion pressure or ophthalmodynamometry (ODM). A reduced MCRAP demonstrates focal ischemia which is most probably caused by proximal vascular disease. TCD is the most sensitive way to determine if stenosis exists in the large basal vessels of the Circle of Willis and the distal ICA's.
​
For additional information about the Falck Multifunction device please visit the link provided above.
TCD with ODM
TCD being performed in ophthalmology has become an emerging market for utilizing TCD for blindness and stroke prevention. The utilization of TCD in the eye care field has also come under scrutiny. TCD in ophthalmology has also been a source of abuse and misuse, primarily caused by misinformation. The conjunction of the Multigon USA TCD with the Falck multifunction device's ODM function is the only proven method of legitimate implementation in Ophthalmology facilities.